TRB-ONC1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

3,171 results for “TRB-ONC1”

Trials

View all 2414 →

Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer

17 participants · First posted Mar 8, 2017

Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

115 participants · First posted Apr 18, 2025

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

18 participants · First posted Jan 11, 2013

Drugs

View all 503 →

ONC1-13B

MDRNA-ONC1

TRB-061

Organizations

View all 25 →

TRB CHEMEDICA

France

TRB Chemedica AG

Germany

TRB KEMEDIKA INTERNESHNL S.A., PREDSTAVITELSTVO

Russia

News

View all 229 →

Transpire Bio Receives FDA Orphan Drug Designation for Inhaled Therapies Targeting IPF and Glioblastoma

US Orphan Drug Market Poised to Exceed $190 Billion by 2030 as FDA Designations Accelerate Rare Disease Therapy Development

TRexBio Initiates First-in-Human Trial of TRB-061, Novel TNFR2 Agonist for Atopic Dermatitis

Page 1 of 318